Open Access Mini Review

Non-Alcohol Fatty Liver Disease Goes Beyond the Liver

GH Koek*

Division of Gastroenterology/Hepatology, Maastricht University Medical Center, Netherlands

Corresponding Author

Received Date: December 10, 2018;  Published Date: December 13, 2018


Non-alcohol fatty liver disease is not only a liver disease but also an important driver in a metabolic disease entity that effects many extrahepatic organs. It is attributing to the development and aggravation of diabetes, cardiovascular diseases and cancer. The change to a hypercaloric, sedentary, lifestyle is the basis of this fast-growing problem. It diagnostic and therapeutic approach is far beyond the liver disease and needs a multidisciplinary, multifactorial approach starting with awareness.

Keywords: Non-alcohol; Fatty liver disease; Non-alcoholic steatohepatitis; Metabolic syndrome; Insulin resistance.

Abbreviations: NAFLD: Non-Alcohol Fatty Liver Disease; NASH: Non-Alcoholic Steatohepatitis; HCC: Hepatocellular Carcinoma; CVD: Cardiovascular Disease

Signup for Newsletter
Scroll to Top